E- to N-cadherin switch in melanoma is associated with decreased expression of phosphatase and tensin homolog and cancer progression

Cadherin switch from E- to N-cadherin in melanoma progression is regulated by the PI3K/PTEN pathway through Twist and Snail

(2012) L. Hao et al.   BRITISH JOURNAL OF DERMATOLOGY

Novel Somatic Mutations to PI3K Pathway Genes in Metastatic Melanoma

(2012) Austin Y. Shull et al.   PLoS One

Melanoblasts in culture as an in vitro system to determine molecular changes in melanoma

(2011) Anja Katrin Bosserhoff et al.   EXPERIMENTAL DERMATOLOGY

Tumor and inflammation markers in melanoma using tissue microarrays

(2011) Trine Ollegaard Jensen et al.   MELANOMA RESEARCH

Cadherin Switching and Bladder Cancer

(2010) Richard T. Bryan et al.   JOURNAL OF UROLOGY

Cell Adhesion Molecules: Role and Clinical Significance in Cancer

(2009) Nektaria Makrilia et al.   CANCER INVESTIGATION

Integrated Molecular and Clinical Analysis of AKT Activation in Metastatic Melanoma

(2009) M. A. Davies et al.   CLINICAL CANCER RESEARCH

Involvement of Members of the Cadherin Superfamily in Cancer

(2009) G. Berx et al.   Cold Spring Harbor Perspectives in Biology

Prognostic Significance of Cadherin-Based Adhesion Molecules in Cutaneous Malignant Melanoma

(2008) G. M. Kreizenbeck et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Subtypes of melanocytes and melanoma cells distinguished by their intercellular contacts: heterotypic adherens junctions, adhesive associations, and dispersed desmoglein 2 glycoproteins

(2008) Steffen Rickelt et al.   CELL AND TISSUE RESEARCH